Centricity Wealth Management LLC Invests $27,000 in Colgate-Palmolive (NYSE:CL)

Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 300 shares of the company’s stock, valued at approximately $27,000.

Other institutional investors have also recently modified their holdings of the company. Chicago Partners Investment Group LLC raised its stake in shares of Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at approximately $1,315,000. Gordian Advisors LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $602,000. Carrera Capital Advisors raised its position in Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after acquiring an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at approximately $4,066,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on CL. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Piper Sandler reduced their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $89.56 on Friday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The business’s 50 day moving average price is $88.94 and its 200-day moving average price is $95.86. The firm has a market capitalization of $72.68 billion, a PE ratio of 25.44, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $84.45 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm earned $0.87 EPS. As a group, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.